145 related articles for article (PubMed ID: 20665843)
1. Solubility, metastable zone width measurement and crystal growth of the 1:1 benzoic acid/isonicotinamide cocrystal in solutions of variable stoichiometry.
Boyd S; Back K; Chadwick K; Davey RJ; Seaton CC
J Pharm Sci; 2010 Sep; 99(9):3779-86. PubMed ID: 20665843
[TBL] [Abstract][Full Text] [Related]
2. Cocrystal screening of hydroxybenzamides with benzoic acid derivatives: a comparative study of thermal and solution-based methods.
Manin AN; Voronin AP; Drozd KV; Manin NG; Bauer-Brandl A; Perlovich GL
Eur J Pharm Sci; 2014 Dec; 65():56-64. PubMed ID: 25218047
[TBL] [Abstract][Full Text] [Related]
3. Predicting the Solubility of Pharmaceutical Cocrystals in Solvent/Anti-Solvent Mixtures.
Lange L; Heisel S; Sadowski G
Molecules; 2016 May; 21(5):. PubMed ID: 27164075
[TBL] [Abstract][Full Text] [Related]
4. Drug-drug cocrystals of antituberculous 4-aminosalicylic acid: Screening, crystal structures, thermochemical and solubility studies.
Drozd KV; Manin AN; Churakov AV; Perlovich GL
Eur J Pharm Sci; 2017 Mar; 99():228-239. PubMed ID: 28011126
[TBL] [Abstract][Full Text] [Related]
5. A thermodynamic based approach on the investigation of a diflunisal pharmaceutical co-crystal with improved intrinsic dissolution rate.
Evora AO; Castro RA; Maria TM; Silva MR; Ter Horst JH; Canotilho J; Eusébio ME
Int J Pharm; 2014 May; 466(1-2):68-75. PubMed ID: 24607201
[TBL] [Abstract][Full Text] [Related]
6. Improving the dissolution and bioavailability of 6-mercaptopurine via co-crystallization with isonicotinamide.
Wang JR; Yu X; Zhou C; Lin Y; Chen C; Pan G; Mei X
Bioorg Med Chem Lett; 2015 Mar; 25(5):1036-9. PubMed ID: 25630224
[TBL] [Abstract][Full Text] [Related]
7. Improving the solubility of dexlansoprazole by cocrystallization with isonicotinamide.
Li J; Wang L; Ye YQ; Fu X; Ren Q; Zhang H; Deng Z
Eur J Pharm Sci; 2016 Mar; 85():47-52. PubMed ID: 26836368
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization and dissolution profile of mycophenolic acid cocrystals.
Zeng QZ; Ouyang J; Zhang S; Zhang L
Eur J Pharm Sci; 2017 May; 102():140-146. PubMed ID: 28254392
[TBL] [Abstract][Full Text] [Related]
9. Generation of 1:1 Carbamazepine:Nicotinamide cocrystals by spray drying.
Patil SP; Modi SR; Bansal AK
Eur J Pharm Sci; 2014 Oct; 62():251-7. PubMed ID: 24931188
[TBL] [Abstract][Full Text] [Related]
10. Identification of New Cocrystal Systems with Stoichiometric Diversity of Salicylic Acid Using Thermal Methods.
Zhou Z; Chan HM; Sung HH; Tong HH; Zheng Y
Pharm Res; 2016 Apr; 33(4):1030-9. PubMed ID: 26744333
[TBL] [Abstract][Full Text] [Related]
11. Nonpolymeric hydrogelator derived from N-(4-pyridyl)isonicotinamide.
Kumar DK; Jose DA; Dastidar P; Das A
Langmuir; 2004 Nov; 20(24):10413-8. PubMed ID: 15544367
[TBL] [Abstract][Full Text] [Related]
12. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride.
Wang X; Wang XJ; Ching CB
Chirality; 2002 May; 14(4):318-24. PubMed ID: 11968072
[TBL] [Abstract][Full Text] [Related]
13. Initial dissolution kinetics of cocrystal of carbamazepine with nicotinamide.
Hattori Y; Sato M; Otsuka M
J Pharm Pharmacol; 2015 Nov; 67(11):1512-8. PubMed ID: 26285918
[TBL] [Abstract][Full Text] [Related]
14. Reaction crystallization of pharmaceutical molecular complexes.
Rodríguez-Hornedo N; Nehm SJ; Seefeldt KF; Pagan-Torres Y; Falkiewicz CJ
Mol Pharm; 2006; 3(3):362-7. PubMed ID: 16749868
[TBL] [Abstract][Full Text] [Related]
15. Complex methodology for rational design of Apremilast-benzoic acid co-crystallization process.
Jirát J; Ondo D; Babor M; Ridvan L; Šoóš M
Int J Pharm; 2019 Oct; 570():118639. PubMed ID: 31465834
[TBL] [Abstract][Full Text] [Related]
16. Ethyl-paraben and nicotinamide mixtures: apparent solubility, thermal behavior and X-ray structure of the 1:1 co-crystal.
Nicoli S; Bilzi S; Santi P; Caira MR; Li J; Bettini R
J Pharm Sci; 2008 Nov; 97(11):4830-9. PubMed ID: 18314888
[TBL] [Abstract][Full Text] [Related]
17. Solubility and some crystallization properties of conglomerate forming chiral drug guaifenesin in water.
Fayzullin RR; Lorenz H; Bredikhina ZA; Bredikhin AA; Seidel-Morgenstern A
J Pharm Sci; 2014 Oct; 103(10):3176-82. PubMed ID: 25091705
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
[TBL] [Abstract][Full Text] [Related]
19. Growth and spectroscopic investigation of a new crystal for NLO applications: C₁₀H₂ ₀KN₅O₉.
Hanumantharao R; Kalainathan S
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Dec; 99():181-8. PubMed ID: 23063862
[TBL] [Abstract][Full Text] [Related]
20. Characterisation, solubility and intrinsic dissolution behaviour of benzamide: dibenzyl sulfoxide cocrystal.
Grossjohann C; Eccles KS; Maguire AR; Lawrence SE; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2012 Jan; 422(1-2):24-32. PubMed ID: 22020274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
